Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.

Fong Y, Dang L, Zhang B, Fintzi J, Chen S, Wang J, Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Yu C, Magaret CA, Molitor C, Borate B, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Mu J, Makowski M, Makhene MK, Nayak SU, Roberts PC, Follmann D, Gilbert PB, Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team

Open source

DOI
10.1093/cid/ciae465
Published
2025 Feb 5
Container
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciae465,
  title = {Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.},
  author = {Fong Y and Dang L and Zhang B and Fintzi J and Chen S and Wang J and Rouphael NG and Branche AR and Diemert DJ and Falsey AR and Losada C and Baden LR and Frey SE and Whitaker JA and Little SJ and Kamidani S and Walter EB and Novak RM and Rupp R and Jackson LA and Yu C and Magaret CA and Molitor C and Borate B and Babu TM and Kottkamp AC and Luetkemeyer AF and Immergluck LC and Presti RM and Bäcker M and Winokur PL and Mahgoub SM and Goepfert PA and Fusco DN and Atmar RL and Posavad CM and Mu J and Makowski M and Makhene MK and Nayak SU and Roberts PC and Follmann D and Gilbert PB and Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team},
  year = {2025},
  journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  doi = {10.1093/cid/ciae465},
  url = {https://doi.org/10.1093/cid/ciae465}
}

RIS

TY  - JOUR
TI  - Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
AU  - Fong Y
AU  - Dang L
AU  - Zhang B
AU  - Fintzi J
AU  - Chen S
AU  - Wang J
AU  - Rouphael NG
AU  - Branche AR
AU  - Diemert DJ
AU  - Falsey AR
AU  - Losada C
AU  - Baden LR
AU  - Frey SE
AU  - Whitaker JA
AU  - Little SJ
AU  - Kamidani S
AU  - Walter EB
AU  - Novak RM
AU  - Rupp R
AU  - Jackson LA
AU  - Yu C
AU  - Magaret CA
AU  - Molitor C
AU  - Borate B
AU  - Babu TM
AU  - Kottkamp AC
AU  - Luetkemeyer AF
AU  - Immergluck LC
AU  - Presti RM
AU  - Bäcker M
AU  - Winokur PL
AU  - Mahgoub SM
AU  - Goepfert PA
AU  - Fusco DN
AU  - Atmar RL
AU  - Posavad CM
AU  - Mu J
AU  - Makowski M
AU  - Makhene MK
AU  - Nayak SU
AU  - Roberts PC
AU  - Follmann D
AU  - Gilbert PB
AU  - Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team
PY  - 2025
JO  - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
DO  - 10.1093/cid/ciae465
UR  - https://doi.org/10.1093/cid/ciae465
ER  -

APA

Y, F., L, D., B, Z., J, F., S, C., J, W., NG, R., AR, B., DJ, D., AR, F., C, L., LR, B., SE, F., JA, W., SJ, L., S, K., EB, W., RM, N., R, R., LA, J., C, Y., CA, M., C, M., B, B., TM, B., AC, K., AF, L., LC, I., RM, P., M, B., PL, W., SM, M., PA, G., DN, F., RL, A., CM, P., J, M., M, M., MK, M., SU, N., PC, R., D, F., PB, G., & Team, C. V. I. L. T. (. S. (2025). Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciae465

Source records